Zdrowie i gospodarka · 08/08/2019
FDA Announces Draft Guidance for Developing Drugs to Treat Fabry Disease
The FDA has released a draft guidance for industry outlining its recommendations for developing drugs to treat Fabry disease, a rare genetic disorder, with the aim of improving clinical trial data quality and accelerating treatment development.